Caris Life Sciences, Inc.
CAI
$16.96
$0.825.08%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2,363.54% | 1,107.19% | -- | -- | -72.51% |
| Total Receivables | 12.90% | 27.08% | -- | -- | -- |
| Inventory | 108.71% | 60.78% | -- | -- | -- |
| Prepaid Expenses | 64.57% | 44.42% | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -53.16% | -52.68% | -- | -- | -- |
| Total Current Assets | 492.28% | 362.52% | -- | -- | -- |
|
|
|||||
| Total Current Assets | 492.28% | 362.52% | -- | -- | -- |
| Net Property, Plant & Equipment | 34.09% | 0.24% | -- | -- | -- |
| Long-term Investments | 0.00% | 0.00% | -- | -- | -- |
| Goodwill | 0.00% | 0.00% | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 17.38% | -6.67% | -- | -- | -- |
| Total Assets | 298.65% | 227.48% | -- | -- | -- |
|
|
|||||
| Total Accounts Payable | 188.13% | 41.07% | -- | -- | -- |
| Total Accrued Expenses | -33.20% | -11.05% | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -90.91% | -90.13% | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 225.80% | 227.87% | -- | -- | -- |
| Total Other Current Liabilities | 225.80% | 227.87% | -- | -- | -- |
| Total Current Liabilities | -11.48% | -23.14% | -- | -- | -- |
|
|
|||||
| Total Current Liabilities | -11.48% | -23.14% | -- | -- | -- |
| Long-Term Debt | 20.45% | 18.56% | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 17.48% | 9.81% | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -99.96% | -99.95% | -- | -- | -- |
| Total Liabilities | -11.84% | -11.69% | -- | -- | -- |
|
|
|||||
| Common Stock & APIC | 2,178,340.69% | 8,268,328.95% | -- | -- | -- |
| Retained Earnings | 1.32% | -3.09% | -- | -- | -- |
| Treasury Stock & Other | 4.01% | 39.95% | -- | -- | -- |
| Total Common Equity | 122.83% | 123.10% | -- | -- | -21.21% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | 5.69% |
|
|
|||||
| Total Common Equity | 122.83% | 123.10% | -- | -- | -21.21% |
| Total Preferred Equity | -- | -- | -- | -- | 5.69% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 267.77% | 308.27% | -- | -- | -1,698.80% |
|
|
|||||